Literature DB >> 21071203

Ubiquitin networks in cancer.

Vladimir Kirkin1, Ivan Dikic.   

Abstract

Conjugation of ubiquitin to cellular proteins has emerged as a post-translational modification, which affects major cellular processes, including cell cycle, proliferation and apoptosis. The ubiquitin-mediated signaling is frequently altered in cancer cells, with several tumor suppressors and oncogenes representing enzymes of the ubiquitin conjugation and deconjugation pathways. Recently, ubiquitination has been involved into selective degradation of both proteins and mitochondria by autophagy. Studying this novel role of ubiquitin can shed light on autophagy as a tumor suppressor mechanism as well as provide insights into the role of autophagy in survival of tumor cells, thus aiding the design of better cancer therapies.
Copyright © 2010 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21071203     DOI: 10.1016/j.gde.2010.10.004

Source DB:  PubMed          Journal:  Curr Opin Genet Dev        ISSN: 0959-437X            Impact factor:   5.578


  38 in total

Review 1.  HECT and RING finger families of E3 ubiquitin ligases at a glance.

Authors:  Meredith B Metzger; Ventzislava A Hristova; Allan M Weissman
Journal:  J Cell Sci       Date:  2012-02-01       Impact factor: 5.285

2.  The Cdc48 protein and its cofactor Vms1 are involved in Cdc13 protein degradation.

Authors:  Guem Hee Baek; Haili Cheng; Ikjin Kim; Hai Rao
Journal:  J Biol Chem       Date:  2012-06-20       Impact factor: 5.157

3.  Expression analysis and association of RBBP6 with apoptosis in colon cancers.

Authors:  Zodwa Dlamini; Charleen Rupnarain; Sarala Naicker; Rodney Hull; Zukile Mbita
Journal:  J Mol Histol       Date:  2016-02-23       Impact factor: 2.611

Review 4.  Ubiquitination in disease pathogenesis and treatment.

Authors:  Doris Popovic; Domagoj Vucic; Ivan Dikic
Journal:  Nat Med       Date:  2014-11-06       Impact factor: 53.440

5.  CHK2 stability is regulated by the E3 ubiquitin ligase SIAH2.

Authors:  C García-Limones; M Lara-Chica; C Jiménez-Jiménez; M Pérez; P Moreno; E Muñoz; M A Calzado
Journal:  Oncogene       Date:  2016-01-11       Impact factor: 9.867

6.  New insights into TRAP1 pathway.

Authors:  Danilo Swann Matassa; Maria Rosaria Amoroso; Francesca Maddalena; Matteo Landriscina; Franca Esposito
Journal:  Am J Cancer Res       Date:  2012-02-19       Impact factor: 6.166

Review 7.  Ubiquitination-mediated regulation of interferon responses.

Authors:  Serge Y Fuchs
Journal:  Growth Factors       Date:  2012-03-07       Impact factor: 2.511

Review 8.  Unraveling the complexity of ubiquitin signaling.

Authors:  Eric R Strieter; David A Korasick
Journal:  ACS Chem Biol       Date:  2012-01-11       Impact factor: 5.100

9.  The E3 ubiquitin ligase CHIP mediates ubiquitination and proteasomal degradation of PRMT5.

Authors:  Huan-Tian Zhang; Ling-Fei Zeng; Qing-Yu He; W Andy Tao; Zhen-Gang Zha; Chang-Deng Hu
Journal:  Biochim Biophys Acta       Date:  2015-12-02

Review 10.  Targeting ubiquitination for cancer therapies.

Authors:  John Kenneth Morrow; Hui-Kuan Lin; Shao-Cong Sun; Shuxing Zhang
Journal:  Future Med Chem       Date:  2015-12-02       Impact factor: 3.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.